Pharmaceutical compounds
US10973817B2 · kind B2 · utility
1Cited by
17References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 31, 2018 |
| Grant date | Apr 13, 2021 |
| Priority date | — |
| Expiry date | Sep 3, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to compounds that inhibit or modulate the activity of Chk-1 kinase. Also provided are pharmaceutical compositions containing the compounds and the therapeutic uses of the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.